MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 64,138 shares, a growth of 1,827.8% from the May 14th total of 3,327 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 1,254,952 shares, the days-to-cover ratio is currently 0.1 days.
MariMed Stock Down 2.7%
MRMD stock traded down $0.00 during midday trading on Tuesday, hitting $0.07. The company’s stock had a trading volume of 624,564 shares, compared to its average volume of 645,909. The company has a market cap of $29.14 million, a PE ratio of -2.43 and a beta of 1.30. MariMed has a 12 month low of $0.06 and a 12 month high of $0.23. The company has a current ratio of 0.95, a quick ratio of 0.34 and a debt-to-equity ratio of 1.67. The firm’s 50-day moving average is $0.08 and its 200-day moving average is $0.08.
MariMed (OTCMKTS:MRMD – Get Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $39.48 million for the quarter, compared to analysts’ expectations of $38.75 million. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%. On average, equities research analysts forecast that MariMed will post -0.04 earnings per share for the current fiscal year.
MariMed Company Profile
MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.
The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.
Featured Articles
- Five stocks we like better than MariMed
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
